Le Lézard
Classified in: Health
Subjects: AWD, WOM

Amendola Communications CEO Jodi Amendola Named One of PR News' Top Women in PR for 2017


SCOTTSDALE, Ariz., Dec. 13, 2017 /PRNewswire/ -- Amendola Communications CEO and co-founder Jodi Amendola has been named to PR News' list of the Top Women in PR for 2017. The prestigious award recognizes women executives who have made bold advances in managing crises, developing brand messages, protecting and building brand reputations, and creating content for digital platforms.

Amendola Communications is a full-service, national public relations, social media and marketing communications firm serving the healthcare, healthcare IT, pharmaceutical and high tech industries. (PRNewsFoto/Amendola Communications) (PRNewsFoto/AMENDOLA COMMUNICATIONS)

To download a photo and bio of Jodi Amendola, click here.

Other honorees include PR executives from the world's biggest public relations agencies, as well as communications leaders at some of the world's best-known companies, including Microsoft, T-Mobile, FedEx, Nissan, General Motors, GE, Southwest Airlines, Bayer and Samsung.

Jodi is an accomplished leader with 25 years of experience in developing, implementing and executing high-impact, integrated business-to-business public relations and marketing campaigns. Beginning in 2003, she pioneered an agency focused squarely on the burgeoning healthcare information technology sector. Over the next decade, Jodi transformed a boutique agency with a handful of small clients into the healthcare IT industry's recognized PR leader?a national, full-service public relations and marketing agency serving dozens of technology innovators ranging from early-stage startups to large public companies.

A hands-on leader, Jodi provides strategic direction and ongoing involvement in all phases of client public relations and marketing programs. She embodies the "client-first" dedication and "get-it-done" attitude that makes Amendola Communications both a fun workplace and a collaborative learning environment. Thanks to Jodi's inspirational leadership and values, clients find that Amendola Communications is more than just an agency, as demonstrated by the partnership mentality and commitment to excellence shared by every member of her team.

"I'm honored to join this remarkable group of accomplished women," said Jodi Amendola. "It's been an amazing PR journey. I am so thankful for the many mentors, clients, business associates, employees and family members who have supported me along the way. I look forward to achieving more milestones and to continuing to help healthcare and healthcare IT companies expand their market dominance and industry thought leadership."

Jodi and the Amendola Communications team are available to discuss your public relations and marketing needs, including media relations, content marketing, branding, digital marketing, search engine marketing, website design and development, and social media. For more information, please visit www.acmarketingpr.com or email [email protected].  

About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation by PRSourceCode for four years running, Amendola Communications represents some of the best-known brands and groundbreaking startups in the healthcare and healthcare IT industries. The organization's seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry's "A Team," visit www.acmarketingpr.com and follow Amendola on Twitter and LinkedIn.

Media Contact:
Marcia Rhodes
Amendola Communications
[email protected]
602-793-1561

 

SOURCE Amendola Communications


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: